• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cost-Benefit Analysis of Real-Time Influenza Testing for Patients in German Emergency Rooms

tetano

Editor, Senior Moderator
Int J Environ Res Public Health. 2019 Jul 3;16(13). pii: E2368. doi: 10.3390/ijerph16132368.
[h=1]Cost-Benefit Analysis of Real-Time Influenza Testing for Patients in German Emergency Rooms.[/h] Diel R[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Nienhaus A[SUP]4,[/SUP][SUP]5[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Seasonal influenza causes significant morbidity worldwide and has a substantial economic impact on the healthcare system.
[h=4]OBJECTIVE:[/h] To assess the cost-benefit relation of implementing a real-time influenza test in emergency rooms (ER) of German hospitals.
[h=4]METHODS:[/h] A deterministic decision-analytic model was developed simulating the incremental costs of using the Solana[SUP]?[/SUP] Influenza A+B test, compared to those of using conventional clinical judgement alone to confirm or exclude influenza in adult ILI (influenza-like illness) patients, in German ER, prior to hospitalization. Direct costs were evaluated from the hospital perspective, considering resource use directly related to influenza testing and treatment, as well as indirect costs incurred by nosocomial influenza transmission.
[h=4]RESULTS:[/h] Through base-case analysis and assuming an influenza prevalence of 42.6%, real-time testing with Solana[SUP]?[/SUP] reduced average costs of hospitalized ILI patients by ?132.61, per tested patient. Moreover, the Solana[SUP]?[/SUP] saved ?6.9 per tested patient in favor of the hospital. In probabilistic sensitivity analysis, under all reasonable assumptions, implementing the Solana[SUP]?[/SUP] saved on average ?144.13 as compared to applying the clinical-judgement-only strategy, thus, it was found to be constantly less expensive.
[h=4]CONCLUSIONS:[/h] Using highly sensitive and specific real-time influenza tests in ILI patients at German ER might significantly reduce hospital expenditures.


[h=4]KEYWORDS:[/h] PCR; cost?benefit analysis; influenza; real-time testing; sensitivity analysis

PMID: 31277347 DOI: 10.3390/ijerph16132368
Free full text
 
Back
Top Bottom